Latest: Godrej Agrovet Q1 FY27 (Apr–Jun 2026) results →This page is Q3 FY26 (Oct–Dec 2025).All Q3 FY26 results →
GA

Godrej Agrovet

Q3 FY26Food Products

Godrej Agrovet Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management said on revenue, margins and capex.

Price₹610
Market cap₹11.1K Cr
P/E23.6
Updated26 Aug 2026
Read3 min read

Get Godrej Agrovet's next results in your feed

The short version

FY '27 growth guidance around 15%, lower than previous targets of 25-30% due to ongoing detailed planning and market assessment (Page 19). FY '27 growth guidance is initially targeted at about 15% revenue growth, which is lower than past guidance of 25-30%, but this is preliminary and subject to annual planning completion by March.

From Godrej Agrovet's Q3 FY26 earnings-call transcript · updated 26 Aug 2026.

Revenue & Sales Performance

  • FY '27 growth guidance around 15%, lower than previous targets of 25-30% due to ongoing detailed planning and market assessment (Page 19).
  • Foods business aims to be a meaningful growth driver, focusing on value-added branded products, innovation, and go-to-market execution (Page 19).
  • Animal Feed segment—cattle feed volume growth around 16.5% for 9 months, indicating strong ongoing momentum (Page 15).
  • Oil palm business expects Fresh Fruit Bunch (FFB) tonnage growth of 12-15% CAGR on a steady-state basis driven by expanded acreage and farmer engagement (Page 9).

2 more points from Godrej Agrovet's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Godrej Agrovet said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • New CPO processing plant in Khammam to go live within 2 months.
  • Downstream refinery for value-added products (cocoa butter substitute, cocoa butter equivalent, CPKO refining) to be commissioned by Q1 of the coming year.
  • These capex projects will significantly ramp up downstream value-added product capacity, increasing contribution from ~8% currently to rapid growth.
  • In Crop Protection, planned launch of 2 in-house products in FY '27.
  • Continuing investment in product pipeline diversification (e.g., Ashitaka maize herbicide launched; Takai multi-crop insecticide launching soon).

2 more points from Godrej Agrovet's call on capex

Create a free account to keep reading this call

Top-ranked in Food Products

Ranked on what management guided this quarter

Guidance-ranked
1Milky Mist Dairy
Rev 1Mar 1
Rev 1Mar 1
3
Rev 1Mar 1
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Godrej Agrovet said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Godrej Agrovet said on order book & pipeline — free account, 30 seconds.

Godrej Agrovet — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Godrej Agrovet Q3 FY26 results — key figures

Godrej Agrovet Q3 FY26 reported results vs Q3 FY25, ₹ crore
₹ CrQ3 FY26Q3 FY25YoYQ2 FY26QoQ
Revenue2,7182,450+10.9%2,567+5.9%
Operating profit (EBITDA)242220+10%213+13.6%
Operating margin9%9%0 pp8%+1 pp
Profit before tax146151-3.3%135+8.1%
Net profit (PAT)1101100%84+31%
EPS (₹)5.975.80+2.9%4.81+24.1%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹2.3K Cr, net profit ₹102 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Food Products this season

  • Annapurna Swadisht (Q3 FY26)

    Revenue for Q3 FY26: ₹394.29 Cr, up 16% YoY from ₹340.07 Cr in Q3 FY25. Key investor presentation takeaways from Annapurna Swadisht Ltd's Q3 FY26 investor prese

  • Narmada Agrobase (Q3 FY26)

    Q3 FY26 Revenues: ₹2,135.35 Lakhs, up from ₹1,383.65 Lakhs in Q3 FY25 . Key investor presentation takeaways from Narmada Agrobase's Q3 FY26 investor presentatio

  • Mukka Proteins (Q3 FY26)

    Q3 FY26 Revenue from Operations: ₹244.6 Cr, down from ₹303.2 Cr in Q3 FY25 (approx. Key investor presentation takeaways from Mukka Proteins Ltd's Q3 FY26 invest

  • Megastar Foods Ltd (Q3 FY26)

    Q3FY26 Revenue from Operations:** ₹14,121 lakhs . Key investor presentation takeaways from Megastar Foods's Q3 FY26 investor presentation — and how it ranks aga

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Godrej Agrovet and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Godrej Agrovet Q3 FY26 results?

FY '27 growth guidance around 15%, lower than previous targets of 25-30% due to ongoing detailed planning and market assessment (Page 19). FY '27 growth guidance is initially targeted at about 15% revenue growth, which is lower than past guidance of 25-30%, but this is preliminary and subject to annual planning completion by March.

What is Godrej Agrovet share price analysis?

Godrej Agrovet currently shows a neutral. The stock trades at a P/E of 23.6 with a market cap of ₹11,052 Cr. Investors should review the full earnings analysis for detailed insights.

Is Godrej Agrovet planning capital expenditure?

New CPO processing plant in Khammam to go live within 2 months.

Keep Godrej Agrovet on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.